This guide explains CPT 96372 in simple terms while addressing real billing risks, payer behavior, and compliance expectations so your practice can protect both revenue and audit readiness
For consumers needing help with getting to optimal GLP-1 levels, working with a medical professional to determine the right mix of medications, supplements and/or CPG products will remain vital in managing their health over the long term. By addressing the preferences of GLP-1 consumerssuch as an increased focus on protein, vegetables and fruits, along with reduced consumption of sugar, carbs and sodiumbrands can align product innovation and marketing strategies with these consumers health goals
Platelet activity was elevated in individuals with type 1 and type 2 diabetes in the early stages, which may increase their vulnerability to CVD (175)
The significant improvements in HOMA-IR demonstrated by the GWMP system with the Release supplement suggest a beneficial role in other disease states including the Metabolic Syndrome or PCOS
Medication choice, dosing strategy, and follow-up cadence are all guided by clinical context rather than templates or trends